focus -WSS

focus

author：explore 2025-09-07 11:17:10 - browse：85

The Amgen booth at ESMO in Madrid. Andrew Joseph/STAT

MADRID — A novel type of immunotherapy from Amgen generated strong response rates in patients with advanced small cell lung cancer, results that could lead to the approval of the drug.

The data, reported here Friday at the annual meeting of European Society for Medical Oncology, come from a Phase 2 trial of the drug, called tarlatamab. But they drew greater interest because Amgen has described the study as “potentially registrational,” and the trial results were also published Friday in the New England Journal of Medicine.

“It’s a single arm study, but the results are amazing,” said Silke Gillessen, the scientific chair of ESMO 2023 and an oncologist at the Oncology Institute of Southern Switzerland, noting that advances in small cell lung cancer have been slow to come.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Guardant Health colon cancer test endorsed by FDA advisory panel

WSS

What's changing in Medicare's open enrollment this year?

Guardant Health colon cancer test endorsed by FDA advisory panel

Researchers CRISPR chickens in bid to protect them from bird flu

New research sheds light on how often breast cancer is overdiagnosed

There’s no way to know how good AI health technologies are

There’s no way to know how good AI health technologies are

explore

focus

leisure time

Dobbs anniversary: the lost opportunity of abortion as health care

A revolution in caring for preterm infants

What does generative AI mean for health care? We asked experts

Louisiana bill approved classifying abortion pills as controlled substances

Drug repurposing or repositioning? The language matters

Achieving telehealth equity for people with hearing loss

Cancer drug shortages should be causing more outrage

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Affirmative action in medical school literally saved lives

Cancer cells are shown to suck energy source from immune cells

entertainment

Massive project maps cells in human brain in unprecedented detail

How doctors and nurses shape Google's AI

Readout LOUD podcast: Merger Mondays, Ozempic panic

Humana CEO Bruce Broussard to step down in 2024

Unmasking the 'centricity' illusion in clinical trials

There’s no way to know how good AI health technologies are

hotspot

knowledge

leisure time

hotspot